SYNLAB AG

SYNLAB AG: SYNLAB affected by cyber-attack in Italy

SYNLAB AG: Release according to Article 111c of the AktG [the German Stock Corporation Act] with the objective of Europe-wide distribution

SYNLAB AG: Dr. Ute Hasholzner, sell

SYNLAB AG: Mathieu Floreani, sell

SYNLAB AG: Sami Badarani, sell

SYNLAB AG: Dr. Wimmer Verwaltungs GmbH & Co. KG, sell

SYNLAB AG: Ebsworth Vermögensverwaltungs Kommanditgesellschaft, sell

SYNLAB AG: Prof. Dr. David Ebsworth, sell

SYNLAB AG: Bekanntmachung der Einberufung zur Hauptversammlung am 17.05.2024 in München mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG

SYNLAB delivers robust performance in FY 2023

Continued strong performance in the third quarter of 2023

SYNLAB AG publishes Joint Reasoned Statement on public acquisition offer by Cinven

SYNLAB launches revolutionary bipolar disorder diagnostic test: myEDIT-B

SYNLAB AG: Ebsworth GmbH, sell

SYNLAB AG: Ebsworth GmbH, sell

SYNLAB AG: SYNLAB enters into investment agreement relating to a public acquisition offer by Cinven

SYNLAB AG: Cinven announces public acquisition offer | Conclusion of Investment Agreement

SYNLAB AG: SYNLAB agrees to sell its veterinary diagnostics business to Mars

SYNLAB AG: Continued strong performance in the second quarter of 2023

SYNLAB AG: SYNLAB plays key role in the largest ever multinational study on cholesterol

SYNLAB AG: SYNLAB invests in innovative Healthcare Centre in Florence